dsip austin Tx Austin Downtown Public Improvement District

Nat Rev Cancer

No serious adverse events have been reported in the available literature at therapeutic doses

Distributors state that the compound is designed to support controlled scientific investigations into peptide stability, structural characteristics, and molecular behavior in multi-compound experimental systems, firmly disclaiming human or veterinary use

A higher rate of fatal adverse reactions, primarily infections, including COVID-19, was observed in patients 65 years old compared to younger adult patients

Here is a summary of the relevant research: In a rat study, DSIP was administered intranasally for 8 days at 120mcg/kg